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Abstract
Aim: Childhood immunization coverage in the United States (U.S.) is often measured at age 24
months or, in the National Immunization Survey (NIS) at age of interview, which is between 19 and
35 months. This paper compares these standards.
Methods: Data from the NIS is used to compare immunization coverage at time of interview,
retrospectively among all children aged 24 or more months at time of interview, and obtained via
multiple imputation (with 10 imputations) for all children, both nationally, by state, and by
demographic groups.
Results: At the national level, the difference between the 19–35 month estimate and the 24 month
complete-case estimate was 1.9 percentage points. For most but not all states and subgroups, the
19–35 month estimate was higher than the 24 month complete-case estimate. The difference
between vaccination coverage measured at 19–35 months and 24 months ranged from -2.3 to 7.5
percentage points among states. For three states, the difference between the 19–35 month and 24
month complete-case estimate was more than 6 percentage points, in twelve states there was a 4–
6 percentage point difference, and in sixteen states a 2–4 percentage point difference. Conversely,
five states had higher 24 month complete-case estimates than 19–35 month estimates.
Conclusion: We found that the coverages at 19–35 and 24 months differ such that they would
rarely be adequate surrogates for one another, particularly at a state level. Multiple imputation,
which is easily implemented, increases precision of estimates of coverage at age 24 months.
1. Introduction
Multiple imputation is a well-established statistical prac-
tice [1-6]; however it is rarely used in health care surveys.
For example, the National Health Interview Survey limits
reports to complete case analyses [7]. Here, we demon-
strate how multiple imputation can be applied to public
health surveys, using data from the National Immuniza-
tion Survey (NIS).
The NIS is the primary means by which immunization
coverage is measured among pre-school aged children in
the U.S. The NIS, conducted annually since 1995 by the
Centers for Disease Control and Prevention (CDC), pro-
vides annual estimates of vaccination coverage among
children aged 19–35 months for the nation and for each
of the 50 states and 28 selected urban areas. Coverage is
measured among children aged 19–35 months, as of the
time of household interview. Each year the CDC
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publishes these NIS estimates of coverage at 19–35
months of age [8,9].
Vaccination coverage is measured by many others at 24
months of age. For example, the Health Plan Employer
Data and Information Set (HEDIS®), of the National
Committee for Quality Assurance, has a Childhood
Immunization Status measure to estimate vaccination
coverage among managed care enrollees who turned two
years old during the measurement year [10,11]. Second,
the Retrospective Surveys of School Enterers' Immuniza-
tion Records measured coverage at 24 months of
age[12,13]. In addition, many state, county, and local sur-
veys assess childhood vaccination coverage at 24 months
of age [14-18]. Finally, CDC also provides coverage esti-
mates at 24 months (and other benchmark ages) from the
NIS on its website http://www.cdc.gov/nip/coverage;
these estimates include only those children in the NIS
who were 24–35 months at the time of interview, thus
representing a subset of children in the complete NIS.
Other benchmark ages are at ages younger than 19
months, so all children are included in these analyses.
It is plausible that coverage measured at 19–35 months
might be higher than that measured at 24 months; some
children have up to 12 months extra to obtain vaccina-
tions and some have up to 6 months less time to obtain
vaccinations [19]. Is 19–35 month coverage higher than
24 month coverage? How different are 19–35 month and
24 month coverage measures, and is the difference uni-
form across states and demographic subgroups? Here, we
compare vaccination coverage measured at 19–35 months
with 24 month coverage, obtained both through com-
plete case analysis and multiple imputation. Further, we
demonstrate how multiple imputation could improve
precision of estimates of 24 months immunization
coverage.
Methods
Survey Design and Collection of Data
The NIS is conducted annually by CDC to obtain
national, state, and selected urban-area estimates of vacci-
nation coverage for the U.S. non-institutionalized popula-
tion of children aged of 19–35 months. The NIS is a
random-digit-dialing survey of households with age-eligi-
ble children followed by a mail survey of the eligible chil-
dren's vaccination providers to obtain the children's
vaccination information [20]. Interviews are conducted
with the household member with best knowledge of the
child's immunizations (a female guardian in about 85%
of the cases). Analyses are restricted to children whose vac-
cination history was verified by their providers.
This study uses data from the 2001 and 2002 NIS. The
2001 NIS included children born February 1998 – June
2000 while the 2002 NIS included children born February
1999 – June 2001. Adequate provider data were obtained
from 23,642 children in the 2001 NIS and 21,410 chil-
dren in the 2002 NIS. A complex weighting methodology
is used in the NIS to adjust estimates for household non-
response, households with multiple phone lines, and vac-
cination history non-response. Details of NIS methodol-
ogy have been published previously, and are not repeated
here [20,21].
Definitions
We evaluated coverage with the 4:3:1:3:3 series. Being
4:3:1:3:3 up-to-date (UTD) was defined as having: 4 or
more doses of diphtheria and tetanus toxoids and pertus-
sis vaccine (DTP), 3 or more doses of poliovirus vaccine,
1 or more dose of any measles-containing vaccine (MCV),
3 or more doses of Haemophilus influenzae type b vaccine
(Hib), and 3 or more doses of hepatitis B vaccine.
Race/ethnicity of the child was respondent-reported dur-
ing the household interview. The ratio of household
income to the poverty level ratio was calculated based
upon reported household income, number of persons in
the household and official U.S. Census Bureau thresholds
for poverty. Children were categorized into one of four
groups: living "above poverty" for household income/
poverty ratios ≥ 125%, living "near poverty" for ratios
100%-124%, "intermediate poverty" for ratios 50%-99%,
and "severe poverty" if the household income/poverty
ratio was less than 50%. This four-class categorization of
poverty better reflects the impact of poverty on vaccina-
tion status than the simple above/below poverty level
dichotomization [22]. For 2001 and 2002 respectively,
86.2 and 87.4 % of the respondents provided household
income data. For the same years, of those providing
household income data, useable provider information
was obtained from 73.6 and 70.2 % of the respondents;
adjustments for provider response propensity are
included in the NIS weights [23].
Three Measures of 4:3:1:3:3 Vaccination Coverage
19–35 Month Coverage
All vaccinations received up to the day that the NIS inter-
view was conducted are included in this measure. This is
the usually quoted coverage [8,9].
24 Month Complete-Case Coverage
For the 24 month complete-case measure, all vaccinations
received up to and including the child's second birthday
are included. This measure is calculated only among the
children in the NIS who were at least 24 months of age at
household interview; children aged 19–23 months at
interview are excluded from this measure. This commonly
used measure for 24 month coverage is statisticallyPopulation Health Metrics 2005, 3:6 http://www.pophealthmetrics.com/content/3/1/6
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Table 1: Comparison of estimated 4:3:1:3:3* vaccination coverage among children using three different measures, United States, 
National Immunization Survey, Q1/2002-Q4/2002†
Level of analysis (percent of 
children aged 19–23 months 
at time of household 
interview, unweighted)
Estimates for 4:3:1:3:3 Coverage (95% Confidence Interval)
19–35 Month (n = 21,410) 24 Month (Complete case) (n 
= 14,910)
24 Month (Imputed)‡ (n = 
21,410)
Overall (30.4%) 74.8 (73.8, 75.8) 72.9 (71.7, 74.1) 72.7 (71.6, 73.8)
Race/Ethnicity:
Hispanic (31.3%) 72.8 (70.4, 75.1) 72.4 (69.6, 75.2) 71.1 (68.6, 73.6)
White, non-Hispanic (29.7%) 77.5 (76.4, 78.8) 75.3 (73.9, 76.7) 75.2 (74.0, 76.5)
Black, non-Hispanic (31.6%) 67.5 (64.6, 70.5) 63.8 (60.0, 67.5) 65.1 (61.8, 68.3)
All others, non-Hispanic 
(31.0%)
75.4 (70.8, 80.0) 74.4 (69.3, 79.5) 74.1 (69.3, 78.9)
Poverty Status:
Above poverty (30.2%) 77.0 (75.9, 78.2) 74.7 (73.3, 76.1) 74.9 (73.6, 76.2)
Near poverty (28.4%) 67.6 (62.4, 72.8) 68.2 (62.7, 73.6) 65.9 (60.6, 71.2)
Intermediate poverty (31.7%) 70.4 (67.1, 73.8) 68.1 (64.0, 72.2) 68.1 (64.6, 71.6)
Severe poverty (31.2%) 67.7 (64.1, 71.4) 68.1 (63.8, 72.3) 66.4 (62.5, 70.3)
State:
Alabama (33.3%) 76.8 (71.5, 82.1) 72.6 (65.6, 79.6) 73.6 (67.9, 79.3)
Alaska (31.3%) 75.3 (69.4, 81.2) 67.8 (60.2, 75.4) 68.1 (61.4, 74.8)
Arizona (28.7%) 67.9 (63.2, 72.7) 68.8 (63.3, 74.4) 66.9 (61.7, 72.0)
Arkansas (27.3%) 71.0 (64.9, 77.1) 69.9 (62.9, 76.9) 70.5 (64.0, 76.9)
California (33.4%) 73.2 (69.4, 77.0) 73.4 (68.9, 77.9) 72.3 (68.2, 76.5)
Colorado (26.3%) 62.8 (56.1, 69.4) 60.1 (52.3, 67.9) 58.7 (51.5, 66.0)
Connecticut (27.3%) 81.9 (76.7, 87.1) 77.9 (71.6, 84.2) 78.3 (72.8, 83.8)
Delaware (31.3%) 78.7 (73.2, 84.2) 78.2 (71.6, 84.8) 77.7 (71.7, 83.7)
District of Columbia (27.4%) 69.7 (62.2, 77.2) 66.7 (58.2, 75.2) 67.3 (59.2, 75.5)
Florida (30.2%) 74.5 (69.8, 79.2) 71.3 (65.4, 77.2) 71.1 (65.7, 76.4)
Georgia (32.8%) 80.4 (76.1, 84.6) 80.3 (75.4, 85.2) 78.7 (74.3, 83.1)
Hawaii (34.6%) 78.7 (73.2, 84.3) 73.4 (66.0, 80.8) 75.8 (69.6, 82.0)
Idaho (31.0%) 69.4 (63.4, 75.3) 66.6 (59.1, 74.0) 67.5 (61.2, 73.8)
Illinois (30.1%) 78.6 (74.3, 82.9) 76.8 (71.4, 82.1) 77.2 (72.7, 81.7)
Indiana (29.8%) 76.0 (71.0, 81.0) 78.3 (72.7, 84.0) 75.1 (69.0, 81.2)
Iowa (31.5%) 78.7 (73.2, 84.2) 77.5 (71.2, 83.9) 77.1 (71.3, 82.8)
Kansas (32.0%) 66.8 (59.9, 73.7) 66.5 (58.5, 74.6) 65.8 (58.8, 72.9)
Kentucky (29.8%) 72.3 (65.9, 78.7) 67.5 (59.6, 75.5) 69.6 (62.5, 76.7)
Louisiana (29.6%) 66.8 (61.2, 72.5) 66.4 (60.1, 72.7) 66.3 (60.3, 72.3)
Maine (29.8%) 80.7 (75.6, 85.8) 76.9 (70.3, 83.5) 76.8 (71.1, 82.5)
Maryland (34.4%) 78.7 (73.1, 84.4) 76.3 (69.7, 82.9) 76.5 (70.4, 82.7)
Massachusetts (28.5%) 86.2 (82.5, 90.0) 81.8 (76.4, 87.1) 82.8 (78.5, 87.1)
Michigan (29.9%) 81.6 (77.2, 86.0) 75.8 (69.5, 82.0) 77.0 (71.8, 82.3)
Minnesota (27.7%) 76.8 (70.3, 83.4) 78.5 (71.8, 85.2) 76.1 (69.2, 83.0)
Mississippi (31.1%) 75.7 (69.2, 82.3) 74.4 (65.9, 82.9) 73.3 (65.9, 80.8)
Missouri (28.8%) 73.0 (66.5, 79.6) 66.9 (58.8, 75.0) 69.2 (62.4, 76.1)
Montana (29.7%) 66.6 (59.8, 73.5) 62.6 (54.2, 71.1) 63.6 (56.5, 70.7)
Nebraska (24.8%) 78.2 (72.6, 83.8) 77.5 (71.0, 84.0) 75.8 (69.5, 82.1)
Nevada (28.3%) 76.4 (70.3, 82.4) 74.4 (67.2, 81.6) 75.9 (69.5, 82.2)
New Hampshire (28.8%) 83.5 (78.6, 88.5) 78.4 (72.0, 84.8) 80.9 (75.4, 86.4)
New Jersey (30.1%) 76.1 (70.7, 81.6) 73.1 (65.8, 80.4) 73.0 (66.7, 79.3)
New Mexico (30.9%) 64.6 (57.9, 71.4) 61.2 (52.6, 69.8) 61.2 (54.0, 68.4)
New York (27.9%) 77.5 (73.2, 81.8) 77.9 (73.0, 82.9) 76.6 (72.1, 81.1)
North Carolina (32.4%) 82.4 (76.9, 88.0) 80.3 (73.5, 87.2) 79.8 (73.7, 85.9)
North Dakota (27.7%) 77.7 (71.0, 84.4) 73.5 (64.9, 82.1) 74.8 (67.7, 81.9)
Ohio (29.5%) 75.0 (70.5, 79.6) 72.2 (66.9, 77.6) 71.9 (66.9, 76.8)Population Health Metrics 2005, 3:6 http://www.pophealthmetrics.com/content/3/1/6
Page 4 of 8
(page number not for citation purposes)
inefficient; information about children aged 19–23
months at time of survey is gathered but not used.
24 Month Imputed Coverage
For this third measure of 4:3:1:3:3 coverage, we modeled
24-month coverage for children aged 19–23 months at
the time of interview and used previously calculated 24
month coverage for children who were 24–35 months at
the time of interview. Modeled immunizations were mul-
tiply imputed using 10 imputations. We divided the chil-
dren into classes based on age at interview and vaccine
doses received by age 19 months. Some children's immu-
nization coverage at age 24 months could be determined
either retrospectively (aged 24 months or more at time of
interview) or prospectively (aged 19–23 months and: had
all doses so will still have them at age 24 months; or had
so few doses at interview that being fully immunized at
age 24 months was implausible). The 24 month immuni-
zation status of some children aged 19–23 months at
interview was uncertain. For these children, we con-
structed a logistic regression model based on demograph-
ics. See Appendix 1 (Additional file 1 and Table 2)for
details.
Statistical Methods
We compared 19–35 month coverage and 24 month cov-
erage, obtained by both methods, nationally, by race/eth-
nicity, by poverty status, and by state for both years of NIS
data. Percentages are reported with 95% confidence inter-
vals. All analyses were conducted using SAS release 8.02
and SAS-callable SUDAAN release 8.0.0, a software pack-
age designed for the analysis of complex survey data.
Results
Table 1 presents 4:3:1:3:3 vaccination coverage estimates,
using the three different measures, nationally and by race/
ethnicity, poverty status, and state (only 2002 results are
presented; 2001 results were similar). The percent of
imputed cases (unweighted) also appears in Table 1.
At the national level, the difference between the 19–35
month estimate and the 24 month complete-case estimate
was 1.9 percentage points. For most states and subgroups,
the 19–35 month estimate was higher than the 24 month
complete-case estimate. This can also be seen in Figure 1,
which displays the difference between the coverage meas-
ures by state. The difference between vaccination coverage
measured at 19–35 months and 24 months ranged from -
2.3 to 7.5 percentage points among states. For three states,
the difference between the 19–35 month and 24 month
complete-case estimate was more than 6 percentage
points, in twelve states there was a 4–6 percentage point
difference, and in sixteen states a 2–4 percentage point
difference. Conversely, five states had higher 24 month
complete-case estimates than 19–35 month estimates;
these were: Indiana, Minnesota, Arizona, New York, and
California (Table 1 and Figure 1). Two income subgroups,
those near poverty and those in severe poverty, also had
higher 24 month complete-case coverage than 19–35
month coverage (Table 1).
Comparing the 24 month complete-case estimates to the
24 month imputed estimates, nationally the imputed
measure was 0.2 percentage points lower than the
complete-case estimate. The imputed estimates were
about equally divided between being greater than or less
Oklahoma (33.6%) 65.3 (57.9, 72.7) 63.1 (54.2, 72.0) 63.3 (55.4, 71.1)
Oregon (33.9%) 70.0 (64.1, 75.9) 64.6 (56.9, 72.3) 65.5 (59.1, 71.8)
Pennsylvania (29.6%) 74.7 (69.3, 80.2) 72.7 (65.9, 79.5) 74.7 (69.0, 80.3)
Rhode Island (32.0%) 84.5 (78.9, 90.1) 78.2 (70.7, 85.6) 81.1 (75.2, 86.9)
South Carolina (32.6%) 78.8 (72.3, 85.3) 77.2 (69.2, 85.1) 77.3 (70.4, 84.1)
South Dakota (33.7%) 79.9 (73.5, 86.3) 77.2 (68.7, 85.7) 75.8 (68.6, 82.9)
Tennessee (31.1%) 78.2 (74.1, 82.3) 75.8 (70.7, 80.9) 76.1 (71.5, 80.7)
Texas (28.6%) 67.9 (62.8, 72.9) 65.2 (59.2, 71.2) 65.3 (60.1, 70.5)
Utah (28.5%) 75.7 (69.9, 81.6) 73.8 (66.8, 80.7) 74.8 (68.6, 81.1)
Vermont (30.6%) 80.9 (76.1, 85.6) 75.2 (69.0, 81.5) 75.4 (69.9, 80.9)
Virginia (31.3%) 72.0 (65.8, 78.2) 68.6 (60.8, 76.3) 70.5 (63.9, 77.1)
Washington (29.6%) 69.2 (64.2, 74.2) 64.8 (59.0, 70.7) 65.1 (59.9, 70.3)
West Virginia (32.4%) 76.9 (70.6, 83.1) 75.8 (69.0, 82.6) 74.2 (67.4, 80.9)
Wisconsin (30.6%) 80.3 (75.9, 84.6) 79.6 (75.1, 84.1) 78.1 (73.6, 82.6)
Wyoming (30.6%) 73.3 (67.0, 79.7) 72.0 (64.4, 79.6) 70.5 (64.0, 77.1)
* 4:3:1:3:3 Four or more doses of any diphtheria and tetanus toxoids and pertussis vaccines including diphtheria and tetanus toxoids, and any 
acellular pertussis vaccine (DTP/DTaP/DT), three or more doses of poliovirus vaccine, one or more doses of any measles containing vaccine 
(MCV), three or more doses of Haemophilus influenzae type b (Hib), and three or more doses of hepatitis B vaccine. † Children in the Q1/2002-
Q4/2002 National Immunization Survey were born between February 1999 and June 2001; n = 21,410. ‡ 10 imputations were performed.
Table 1: Comparison of estimated 4:3:1:3:3* vaccination coverage among children using three different measures, United States, 
National Immunization Survey, Q1/2002-Q4/2002† (Continued)Population Health Metrics 2005, 3:6 http://www.pophealthmetrics.com/content/3/1/6
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than the 24 month complete-case estimates (Table 1). As
expected, the 24 month imputed estimates had, with the
exception of two states (Indiana and Minnesota), nar-
rower confidence intervals than the 24 month complete
case estimates. The authors found no explanation of why
this was so; in 2001 (results not presented), only one state
(North Carolina) had a complete case confidence interval
that was narrower than the imputed confidence interval.
The percentage decrease in standard error from using the
multiple imputation measure of 4:3:1:3:3 coverage over
using the complete case estimate was 8% ([SE complete
case-SE imputed case]/ [SE complete case]= [0.61–0.56]/
[0.61]= 0.08). When the imputation model was applied to
those for which 24 month coverage was known, the
immunization status was correctly assigned for approxi-
mately 60%. Note that random variation among imputa-
tions was added as an additional component to the
model.
Discussion
The problem of determining immunization coverage at
age 24 months is well-suited to multiple imputation. Data
are missing at random. The NIS telephone interviews are
conducted on a national basis throughout the year, mak-
ing the age of child at time of telephone interview
independent of demographics. Age of child at household
Difference Between the 19–35 month, 24 month complete-case, and the 24-month multiple-imputation* estimates, National  Immunization Survey, 2002 Figure 1
Difference Between the 19–35 month, 24 month complete-case, and the 24-month multiple-imputation* estimates, National 
Immunization Survey, 2002.
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interview alone determines if a child's immunization cov-
erage at age 24 months is missing.
In comparing coverages, we found that, at the national
level, 19–35 month 4:3:1:3:3 coverage was slightly higher
than both the 24 month complete-case and imputed esti-
mates (Table 1). However, at the state level there were
much larger differences. For five states the 24 month cov-
erage estimates were larger than the 19–35 month esti-
mates. For 2001 (data not shown), 11 states, all different
from those of 2002, had larger 24 month coverage than
19–35 month coverage. The authors found no common
characteristics of these states; perhaps larger 24 month
coverage is simply random variation, and is not explaina-
ble by state characteristics.
How can 24 month coverage estimates be larger than 19–
35 month coverage? Approximately 29% (percent varies
slightly among years) of the children in the NIS are
younger than 24 months at time of household interview.
In the 24 month complete-case estimate, these children
are excluded from both numerator and denominator. If,
because of lower incidence of delayed vaccination or
increased incidence of very delayed vaccination (age 24–
35 months) or by chance, coverage among 24–35 month
old children was substantially lower than among those
aged 19–23 months, the estimate for 19–35 month olds
would be lower than coverage measured at 24 months of
age.
We found that our multiple imputation resulted in
slightly narrower confidence intervals for all except two
states. One could narrow the confidence intervals for the
complete case analysis by increasing the sample size. If we
can assume that the hypothetical increased sample size
would not change the design effect, then to achieve on a
national scale the same precision from the complete case
analysis that multiple imputation yielded would require a
sample size 1.19 times as large ([width of complete case
confidence interval/width of imputed case confidence
interval]2). To increase the NIS sample size by this magni-
tude would require an addition of approximately $2.6
million to the survey budget. The improvement in preci-
sion is more substantial for some states; as an arbitrarily
chosen example, we would need a sample 1.51 times as
large in Alabama to get the same improvement in preci-
sion that we get from imputation by increasing sample
size. Thus, use of multiple imputation produces an essen-
tially cost-free increase in precision of the 24 month vac-
cination coverage estimates that would be costly and
difficult to equal through increased sample size alone.
Additionally, because the data are not missing completely
at random, but are missing at random, generally there is
bias in complete-case methods that is mostly removed
Table 2: Logistic regression model used for the multiple imputation analysis
Variable Odds for intercept, odds ratio otherwise 95% confidence interval
Intercept 0.06 0.03 – 0.10
Race: Hispanic 0.79 0.61 – 1.03
White, non-Hispanic REF REF
Black, non-Hispanic 0.73 0.53 – 0.99
All others, non-Hispanic 0.95 0.61 – 1.46
Census Region: Northeast 1.90 1.36 – 2.65
Midwest 1.42 1.04 – 1.94
South 1.28 0.97 – 1.69
West REF REF
MSA*: MSA, central city REF REF
MSA, non-central city 1.20 0.95 – 1.51
Non-MSA 0.91 0.68 – 1.23
Number of DTP† doses at 19 months: 4+ doses‡ 2.94 2.37 – 3.65
3 doses REF REF
Number of MCV§ doses at 19 months: 1+ doses|| 2.82 2.11 – 3.80
0 doses REF REF
Number of hepatitis B doses at 19 months: 3+ doses¶ 3.86 2.82 – 5.28
2 doses 0 0
* Metropolitan Statistical Area (MSA)
† Diphtheria and tetanus toxoids, and any acellular pertussis vaccine (DTP)
‡ Four or more doses (4+)
§Measles-containing vaccine (MCV)
|| One or more doses (1+)
¶Three or more doses (3+)Population Health Metrics 2005, 3:6 http://www.pophealthmetrics.com/content/3/1/6
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(depending on the quality of the imputation model) by
multiple imputation.
The potential precision gains to be achieved must be con-
sidered in light of drawbacks inherent in this approach.
One potential drawback of using multiple imputation is
that a predictive model must be specified. However, a
body of both analytic and simulation-based work sup-
ports the claim that the model used in multiple imputa-
tion can be quite far off and still result in substantially
better answers than other methods; thus the importance
of the "multiple" part of multiple imputation.[24] In this
study our model performed only modestly in classifying
UTD status of those for whom we knew UTD status; vac-
cination behaviors involve a complex, and not fully
understood interaction of personal beliefs, attitudes, and
knowledge, of health provider variables, and system
variables.
Conclusion
Many published results concern vaccination coverage
among 19–35 month old children [8,9,22]. This is a mov-
ing cohort, consisting of children whose age is between 19
and 35 months at any point during a given calendar year;
many children in one year's cohort are also in the next
year's. Coverage for 19–35 month old children reflects
vaccination status at time of household interview; a
child's age at time of interview impacts coverage, with
older children more likely to be vaccinated. In short, cov-
erage among 19–35 month old children is difficult to
interpret while coverage at age 24 months is readily inter-
preted, and is a common standard [10-18].
Can one directly compare 19–35 month old coverage
with 24 month coverage? We have shown that 19–35
month old coverage can be either smaller or greater than
24 month coverage. Thus, neither coverage measure
bounds the other. We have shown that coverage at 19–35
months and at 24 months can, at best, serve as crude sur-
rogates for one another, particularly at a state level. We
would, for most purposes, caution against direct compar-
ison (although, for those who wish to make direct com-
parison, our methods provide a measure of the likely
differences between these immunization coverages).
We have shown that multiple imputation can yield more
precise estimates of coverage at 24 months than is
obtained by a complete case analysis, at essentially no
increase in cost. Similar methods are applicable to other
public health surveys. With today's limited resources for
public health surveys, we recommend that multiple impu-
tation be used, where appropriate, to improve precision.
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